Precision treatment for multiple sclerosis: Maximising the effect of immunomodulatory therapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1129189

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Response to therapy varies greatly among patients with multiple sclerosis (MS). The current lack of individualised MS therapy may lead to suboptimal MS management and accumulation of preventable disability. We will use MSBase, a large international MS cohort, to evaluate the effect of different treatment strategies and of highly effective and novel therapies. Identifying the patients who will benefit from these therapies, we will provide the key evidence for individualised MS management.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2021

Funding Scheme: Project Grants

Funding Amount: $537,272.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Central Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

disease outcome | individualising management | multiple sclerosis (MS) | prediction | therapy

Related Links